Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Laquinimod in Relapsing Remitting Multiple Sclerosis
NCT00349193Phase 2Completed
- Sponsor
- Teva Pharmaceutical Industries Ltd.
- Start
- Mar 2005
- Primary completion
- Jun 2006
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of laquinimod in relapsing-remitting multiple sclerosis (RRMS), sponsored by Teva Pharmaceutical Industries Ltd.. Started Mar 2005; status: completed.
02
Drugs
laquinimod
03
Conditions
relapsing-remitting multiple sclerosis (RRMS)
Beyond the preview
Go deeper on NCT00349193.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00349193.